Who we are
As a family-held company, we are cognisant of how work shapes who we are and who we aspire to become.
Our Aspiration
More than one billion people around the world live with iron deficiency anaemia, making this one of the largest global health challenges of our time. At Pharmacosmos, we want to change the way iron deficiency is prevented and treated in humans and animals. We do so by striving to stay at the scientific forefront and by partnering with pioneers in scientific communities. We seek to enhance patient safety and recovery while simplifying treatment management. Our innovative principle is to help healthcare professionals, patients and society to achieve more by having to do less.
COMMITTED TO QUALITY
Quality is our source of inspiration. Quality drives our results. It represents our aspiration for excellence and our focus on driving continual improvements. For our partners and end-users, quality must always be tangible in our products, processes and people. This way, quality is the promise we keep every day.
PEOPLE DRIVEN
We are a family-held company built on passionate, knowledgeable people. We value integrity, open-mindedness and respect and are guided by these values in all our endeavours. We respect each individual who becomes a part of our journey, from our employees and partners to our end-users. And we recognise that the strength in all our collaborations is trust.
INNOVATING FOR BETTER LIVES
Innovation is essential in our quest to improve the lives of humans and animals. We seek to address unmet needs through our expertise in iron and carbohydrate-based pharmaceuticals. We believe in a holistic and collaborative approach to research and innovation, so we work together with the scientific and medical communities to set new standards.
PHARMACOSMOS IS...
A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.
Global presence
Our global presence is strong, thanks to our skilled colleagues and partners in all the major pharmaceutical markets. Today, we are represented in more than 40 countries. This is the key to our accelerated growth and will lay the foundation for future regional and global innovation.
